REFERENCES
1. Middleton BF, Danchin M, Fathima P, Bines JE, Macartney K, Snelling
TL. Review of the health impact of the oral rotavirus vaccine program in
children under 5 years in Australia: 2006 - 2021. Vaccine.2023;41(3):636-648.
2. Collaborators GBDDD. Estimates of the global, regional, and national
morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a
systematic analysis for the Global Burden of Disease Study 2016.Lancet Infect Dis. 2018;18(11):1211-1228.
3. Lau YL, Fan Leung T, Sirvan Cetin B, et al. Safety and reactogenicity
of a liquid formulation of human rotavirus vaccine (porcine
circovirus-free): A phase III, observer-blind, randomized, multi-country
study. Vaccine. 2022;40(14):2184-2190.
4. Hartman RM, Cohen AL, Antoni S, et al. Risk Factors for Mortality
Among Children Younger Than Age 5 Years With Severe Diarrhea in Low- and
Middle-income Countries: Findings From the World Health
Organization-coordinated Global Rotavirus and Pediatric Diarrhea
Surveillance Networks. Clin Infect Dis. 2023;76(3):e1047-e1053.
5. Caddy S, Papa G, Borodavka A, Desselberger U. Rotavirus research:
2014-2020. Virus Res. 2021;304:198499.
6. Du Y, Chen C, Zhang X, et al. Global burden and trends of rotavirus
infection-associated deaths from 1990 to 2019: an observational trend
study. Virol J. 2022;19(1):166.
7. Bishop RF DG, Holmes IH, Ruck BJ. Virus particles in epithelial cells
of duodenal mucosa from children with acute non-bacterial
gastroenteritis. Lancet. 1973;2(7841):1281-1283.
8. Mhango C, Mandolo JJ, Chinyama E, et al. Rotavirus Genotypes in
Hospitalized Children With Acute Gastroenteritis Before and After
Rotavirus Vaccine Introduction in Blantyre, Malawi, 1997-2019. J
Infect Dis. 2022;225(12):2127-2136.
9. Matthijnssens J, Otto PH, Ciarlet M, Desselberger U, Van Ranst M,
Johne R. VP6-sequence-based cutoff values as a criterion for rotavirus
species demarcation. Arch Virol. 2012;157(6):1177-1182.
10. Mihalov-Kovacs E, Gellert A, Marton S, et al. Candidate new
rotavirus species in sheltered dogs, Hungary. Emerg Infect Dis.2015;21(4):660-663.
11. Banyai K, Kemenesi G, Budinski I, et al. Candidate new rotavirus
species in Schreiber’s bats, Serbia. Infect Genet Evol.2017;48:19-26.
12. Johne R, Tausch SH, Grutzke J, et al. Distantly Related Rotaviruses
in Common Shrews, Germany, 2004-2014. Emerg Infect Dis.2019;25(12):2310-2314.
13. Luo S, Chen X, Yan G, et al. Emergence of human-porcine reassortment
G9P[19] porcine rotavirus A strain in Guangdong Province, China.Front Vet Sci. 2022;9:1111919.
14. Hokororo A, Kidenya BR, Seni J, Mapaseka S, Mphahlele J, Mshana SE.
Predominance of rotavirus G1[P8] genotype among under-five children
with gastroenteritis in Mwanza, Tanzania. J Trop Pediatr.2014;60(5):393-396.
15. Lucien MAB, Esona MD, Pierre M, et al. Diversity of rotavirus
strains circulating in Haiti before and after introduction of monovalent
vaccine. IJID Reg. 2022;4:146-151.
16. Doro R, Laszlo B, Martella V, et al. Review of global rotavirus
strain prevalence data from six years post vaccine licensure
surveillance: is there evidence of strain selection from vaccine
pressure? Infect Genet Evol. 2014;28:446-461.
17. Li J, Zhang Y, Yang Y, et al. Effectiveness of Lanzhou lamb
rotavirus vaccine in preventing gastroenteritis among children younger
than 5 years of age. Vaccine. 2019;37(27):3611-3616.
18. Chen S, Gao S, Li J, Li J, Duan ZJ. Cost-benefit analysis of
rotavirus vaccine included in the national immunization program in
China. Vaccine. 2023;41(2):547-554.
19. Carvalho MF, Gill D. Rotavirus vaccine efficacy: current status and
areas for improvement. Hum Vaccin Immunother.2019;15(6):1237-1250.
20. Cates JE, Tate JE, Parashar U. Rotavirus vaccines: progress and new
developments. Expert Opin Biol Ther. 2022;22(3):423-432.
21. Wu Z, Li Q, Liu Y, et al. Efficacy, safety and immunogenicity of
hexavalent rotavirus vaccine in Chinese infants. Virol Sin.2022;37(5):724-730.
22. Lu L, Zhong H, Jia R, et al. Prevalence and genotypes distribution
of group A rotavirus among outpatient children under 5 years with acute
diarrhea in Shanghai, China, 2012-2018. BMC Gastroenterol.2022;22(1):217.
23. Phan TG, Khamrin P, Quang TD, et al. Detection and genetic
characterization of group A rotavirus strains circulating among children
with acute gastroenteritis in Japan. J Virol.2007;81(9):4645-4653.
24. Iturriza-Gomara M, Kang G, Gray J. Rotavirus genotyping: keeping up
with an evolving population of human rotaviruses. J Clin Virol.2004;31(4):259-265.
25. Gouvea V GR, Woods P, Taniguchi K, Clark HF, Forrester B, Fang ZY.
Polymerase chain reaction amplification and typing of rotavirus nucleic
acid from stool specimens. J Clin Microbiol. 1990;28(2):276-282.
26. Simmonds MK, Armah G, Asmah R, et al. New oligonucleotide primers
for P-typing of rotavirus strains: Strategies for typing previously
untypeable strains. J Clin Virol. 2008;42(4):368-373.
27. Wang JX, Zhou HL, Mo ZJ, et al. Burden of viral gastroenteritis in
children living in rural China: Population-based surveillance. Int
J Infect Dis. 2020;90:151-160.
28. Wang LP, Zhou SX, Wang X, et al. Etiological, epidemiological, and
clinical features of acute diarrhea in China. Nat Commun.2021;12(1):2464.
29. Lu JG, B.C. Zhang, L.P. Mei, K.W. Lu, X.Y. Lu, Y.H. Rotavirus
vaccine coverage in the 2013-2020 birth cohorts in Minhang district of
Shanghai. Chinese Journal of Vaccines and Immunization2021;27(6):695-698.
30. Fu C, Wang M, Liang J, He T, Wang D, Xu J. Effectiveness of Lanzhou
lamb rotavirus vaccine against rotavirus gastroenteritis requiring
hospitalization: a matched case-control study. Vaccine.2007;25(52):8756-8761.
31. Fu C, He Q, Xu J, et al. Effectiveness of the Lanzhou lamb rotavirus
vaccine against gastroenteritis among children. Vaccine.2012;31(1):154-158.
32. Wu D, Yen C, Yin ZD, et al. The Public Health Burden of Rotavirus
Disease in Children Younger Than Five Years and Considerations for
Rotavirus Vaccine Introduction in China. Pediatr Infect Dis J.2016;35(12):e392-e398.
33. Yu J, Lai S, Geng Q, et al. Prevalence of rotavirus and rapid
changes in circulating rotavirus strains among children with acute
diarrhea in China, 2009-2015. J Infect. 2019;78(1):66-74.
34. do Nascimento LG, Fialho AM, de Andrade J, de Assis RMS, Fumian TM.
Human enteric adenovirus F40/41 as a major cause of acute
gastroenteritis in children in Brazil, 2018 to 2020. Sci Rep.2022;12(1):11220.
35. Maison N, Peck A, Illi S, et al. The rising of old foes: impact of
lockdown periods on ”non-SARS-CoV-2” viral respiratory and
gastrointestinal infections. Infection. 2022;50(2):519-524.
36. Grochowska M, Ambrozej D, Wachnik A, Demkow U, Podsiadly E, Feleszko
W. The Impact of the COVID-19 Pandemic Lockdown on Pediatric
Infections-A Single-Center Retrospective Study. Microorganisms.2022;10(1).
37. Hoque SA, Khandoker N, Thongprachum A, et al. Distribution of
rotavirus genotypes in Japan from 2015 to 2018: Diversity in genotypes
before and after introduction of rotavirus vaccines. Vaccine.2020;38(23):3980-3986.
38. Baoming Jiang JRG, Roger I Glass. The role of serum antibodies in
the protection against rotavirus disease: an overview. Clin Infect
Dis. 2002;34(10):1351-1361.
39. Elias MM. Distribution and titres of rotavirus antibodies in
different age groups. J Hyg (Lond). 1977;79(3):365-372.
40. Satayarak J, Strauss ST, Duangdee C, et al. Prevalence and diversity
of human rotavirus among Thai adults. J Med Virol.2020;92(11):2582-2592.
41. Wang SJ, Chen LN, Wang SM, et al. Genetic characterization of two
G8P[8] rotavirus strains isolated in Guangzhou, China, in 2020/21:
evidence of genome reassortment. BMC Infect Dis. 2022;22(1):579.
42. Taniguchi K UT, Urasawa S. Independent segregation of the VP4 and
the VP7 genes in bovine rotaviruses as confirmed by VP4 sequence
analysis of G8 and G10 bovine rotavirus strains. J Gen Virol.1993;74(Pt 6):1215-1221.
43. Hasegawa A, Inouye S, Matsuno S, Yamaoka K, Eko R, Suharyono W.
Isolation of human rotaviruses with a distinct RNA electrophoretic
pattern from Indonesia. Microbiol Immunol. 1984;28(6):719-722.
44. Tapia MD, Armah G, Breiman RF, et al. Secondary efficacy endpoints
of the pentavalent rotavirus vaccine against gastroenteritis in
sub-Saharan Africa. Vaccine. 2012;30 Suppl 1:A79-85.
45. Ma W, Wei Z, Guo J, et al. Effectiveness of Pentavalent Rotavirus
Vaccine in Shanghai, China: A Test-Negative Design Study. J
Pediatr. 2023;259:113461.
46. Mukhopadhya I, Murdoch H, Berry S, et al. Changing molecular
epidemiology of rotavirus infection after introduction of monovalent
rotavirus vaccination in Scotland. Vaccine. 2017;35(1):156-163.
47. Sadiq A, Bostan N, Yinda KC, Naseem S, Sattar S. Rotavirus:
Genetics, pathogenesis and vaccine advances. Rev Med Virol.2018;28(6):e2003.
48. Pindyck T, Tate JE, Parashar UD. A decade of experience with
rotavirus vaccination in the United States - vaccine uptake,
effectiveness, and impact. Expert Rev Vaccines.2018;17(7):593-606.
49. Hoa-Tran TN, Nakagomi T, Vu HM, et al. Abrupt emergence and
predominance in Vietnam of rotavirus A strains possessing a bovine-like
G8 on a DS-1-like background. Arch Virol. 2016;161(2):479-482.